Robert Deans | Chief Innovation Officer
BlueRock Therapeutics

Robert Deans, Chief Innovation Officer, BlueRock Therapeutics

Appearances:



Conference Day 1 - Tuesday 31st March 2020 @ 17:00

Exploring the rise of machine learning and AI in next generation bioprocesses: Single Cell RNA sequencing to drive innovation and quality in iPSC therapeutics

last published: 24/Jan/20 15:15 GMT

back to speakers